Diana M. Bond

Diana M. Bond

Auto-generated profile, based on publicly available information

Diana M. Bond

Child Population and Translational Health Research Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, the University of Sydney Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2017 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
DBDiana M Bond
Diana M Bond
PMPhilippa Middleton
Philippa Middleton
Kate LevettKate Levett
Kate Levett
DHDavid P van der Ham
David P van der Ham
CCCaroline A Crowther
Caroline A Crowther
JMJonathan Morris
Jonathan Morris

25 November 2016 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
PGPaul Gardiner
Paul Gardiner
AKAlison L. Kent
Alison L. Kent
VRViviana Rodriguez
Viviana Rodriguez
AWAleena M. Wojcieszek
Aleena M. Wojcieszek
DEDavid Alan Ellwood
David Alan Ellwood
VFVicki Flenady
Vicki Flenady
Stillbirths and neonatal deaths are devastating events for both parents and clinicians and are global public health concerns. Careful clinical management after these deaths is required, including appropriate investigation and assessment to determine cause (s) to prevent future losses, and to improve bereavement care for families. An educational programme for health care professionals working in maternal and child health has been designed to address these needs according to the Perinatal Society of Australia and New Zealand Guideline for Perinatal Mortality: IMproving Perinatal mortality Review and Outcomes Via Education (IMPROVE). The programme has a major focus on stillbirth and is delivered as six interactive skills-based stations. We aimed to determine participants’ pre- and post-programme knowledge of and confidence in the management of perinatal deaths, along with satisfaction with the programme. We also aimed to determine suitability for international use. The IMPROVE programme was delivered to health professionals in maternity hospitals in all seven Australian states and territories and modified for use internationally with piloting in Vietnam, Fiji, and the Netherlands (with the assistance of the International Stillbirth Alliance, ISA). Modifications were made to programme materials in consultation with local teams and included translation for the Vietnam programme. Participants completed pre- and post-programme evaluation questionnaires on knowledge and confidence on six key components of perinatal death management as well as a satisfaction questionnaire. Over the period May 2012 to May 2015, 30 IMPROVE workshops were conducted, including 26 with 758 participants in Australia and four with 136 participants internationally. Evaluations showed a significant improvement between pre- and post-programme knowledge and confidence in all six stations and overall, and a high degree of satisfaction in all settings. The IMPROVE programme has been well received in Australia and in three different international settings and is now being made available through ISA. Future research is required to determine whether the immediate improvements in knowledge are sustained with less causes of death being classified as unknown, changes in clinical practice and improvement in parents’ experiences with care. The suitability for this programme in low-income countries also needs to be established.

19 May 2017 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
DBDiana M. Bond
Diana M. Bond
JMJonathan M. Morris
Jonathan M. Morris
Nashaat NassarNashaat Nassar
Nashaat Nassar
Mastitis and accompanying pain have been associated with the cessation of breastfeeding. Mastitis is an inflammatory condition of the breast and may be a result of decreased immunity and a lowered resistance to infection. Mastitis affects up to one in five breastfeeding women with most episodes occurring in the first 6–8 weeks postpartum. Antibiotics are often used in the treatment of mastitis, but have not been popular or proven effective as a preventative agent. The WHO has highlighted significant concerns relating to adverse harms of antibiotic use with the production of antibiotic-resistant strains of disease organisms. Increasing research suggests that specific probiotic bacteria possess significant anti-inflammatory properties and supports their potential use as immunomodulatory agents. While animal studies have shown promising results in the use of probiotics for preventing mastitis, their use in human trials has had limited investigation. The aim of this study is to evaluate the effectiveness of oral probiotics for the prevention of mastitis in breastfeeding women. APProve (CAn Probiotics ImProve Breastfeeding Outcomes?) is a double-blind randomised controlled trial designed to assess outcomes between breastfeeding women ingesting a probiotic versus a placebo daily for 8 weeks following birth. A total of 600 women (300 to each arm) who intend to breastfeed will be randomised after the birth of a term, healthy infant. Daily and weekly surveys for 8 weeks and follow-up surveys at 2, 6 and 12 months after birth will assess the primary outcome of mastitis in the first 8 weeks following birth as well as secondary maternal outcomes of breastfeeding duration (total/partial), antibiotic use, maternal health and well-being, and treatment compliance; and infant outcomes including gastroenteritis, infant health and well-being and growth and development. The acceptability and compliance using a novel mobile phone application system will also be evaluated. There is an urgent need to explore safe and effective alternatives for preventing mastitis in breastfeeding women. This trial seeks to provide evidence for such an alternative in the form of probiotics, which may also increase breastfeeding duration, providing long-term health, cognitive and developmental benefits for children. Decreased antibiotic usage also benefits the community and health system. Australian New Zealand Clinical Trials Registry: ACTRN12615000923561 . Date of registration: 4th September, 2015, retrospectively registered.

24 November 2015 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
DBDiana M Bond
Diana M Bond
AGadrienne gordon
adrienne gordon
JHJon Hyett
Jon Hyett
BVBradley de Vries
Bradley de Vries
ACAngela E Carberry
Angela E Carberry
JMJonathan Morris
Jonathan Morris

22 January 2023 in Clinical Obesity
Verified
Journal Article
Open access
DBDiana M. Bond
Diana M. Bond
RSRadhika Seimon
Radhika Seimon
FSFrancisco J. Schneuer
Francisco J. Schneuer
LBLouise A. Baur
Louise A. Baur
MCMaria Craig
Maria Craig
NNNatasha Nassar
Natasha Nassar
Summary: Recent evidence suggests the immediate effects of the COVID‐19 lockdowns and restrictions have resulted in increased weight in children and adolescents. However, the longer‐term effects have not been assessed. The aim of this study was to examine the impact and longer‐term effects of the COVID‐19 pandemic on BMI and weight status of children and adolescents. This study used routinely collected clinical data from the Sydney Children's Hospitals Network, comprising two socio‐demographically diverse children's hospitals in New South Wales, Australia from 2018 to 2021. Of 245 836 individuals ≤18‐years assessed, mean BMI percentile increased from 58.7 (SD 31.6) pre‐COVID‐19 to 59.8 (SD 31.7) (p < .05) post‐restrictions and overweight/obesity increased by 5.5% (obesity alone 6.3%), predominantly in children <12‐years and from lower socioeconomic backgrounds. The trend in BMI percentile was steady pre‐COVID‐19 (β = −0.03 [95% CI −0.07, 0.01]), peaked immediately following COVID‐19 restrictions (β = 1.28 [95% CI 0.24, 2.32]) and returned to pre‐pandemic levels over ensuing 21 months (β = −0.04 [95% CI –0.13, 0.04]). Routine anthropometric measurement facilitates ongoing monitoring and evaluation of the weight status of children and adolescents, helping to identify those at‐risk. Despite initial BMI and weight increases among children and adolescents, longer‐term follow‐up highlighted a return to pre‐pandemic rates, possibly attributed to state‐wide policies aimed at reducing childhood obesity.

4 August 2017 in Australian and New Zealand Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
DBDiana Bond
Diana Bond
Camille Raynes-GreenowCamille Raynes-Greenow
Camille Raynes-Greenow
AGadrienne gordon
adrienne gordon